Perseus Proteomics
About:
Perseus Proteomics is a biotech company that offers antibody drug development, antibody research support services, and sales.
Website: https://www.ppmx.com/
Top Investors: SMBC Venture Capital, Mitsubishi UFJ Capital, SBI Investment, Mizuho Capital, DBJ Capital
Description:
PePerseus Proteomics is a drug discovery biotechnology venture that uses advanced antibody technology to pursue superior antibody production technology and create new medicines powerfully for people around the world who are waiting for better medical care .
Total Funding Amount:
5.44B JPY
Estimated Revenue Range:
Less than $1M
Headquarters Location:
Tokyo, Tokyo, Japan
Founded Date:
2001-02-01
Contact Email:
info(AT)ppmx.com
Founders:
Takuya Yokokawa
Number of Employees:
11-50
Last Funding Date:
2020-11-30
IPO Status:
Private
Industries:
© 2025 bioDAO.ai